CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AMGN

AMG 193

Phase 2
Amgen Inc. (AMGN)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
AMGNPhase 2

anvumetostat Phase 2 Est. Readout

AMG 193
Oct 2026~
CT.gov
00%
Competitive Landscape

0 competitors in MTAP-deleted NSCLC

View Full Landscape
Drug Information

Target Indication

MTAP-deleted NSCLC

Clinical Trial

NCT06593522

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.